Surgical
Oncology
1993; 2: 77-81
Testicular cytotoxicity F. E. JOHNSON*, Departments
Although
of *Surgery
the
previous
ally employed
by histology
repopulation
index
and kidney
histology
lar atrophy
and oligospermia testicular
at high dosages appears Oncology
index.
evaluated
atrophy,
at low
oligospermia
(500 and 700 mg kg-’
cancer treatment,
therapy
for
thousand
number
of long-term
cancer
successfully
treated
infertility,
and germinal
body weight
agents
been oligo-
long
after
completion
population
clinical
of
Surgery,
observed
This model
damage.
Surgical
on are
effects
of
small
size
their
small
blood
evaluation. method
these
human often
male
post-pubertal
male to
anti-neoplastic hinders
surgical
volume
We are currently to address
this
limits invesissue
in
Frank
E. Johnson,
University
Medical
MD,
Department
Center,
3635
of Vista
rats were
to tap water
housed
5001. Approximately
health
screening
AAALAC
(American
of Laboratory
and institutional
the performance Procarbazine LaRoche,
Association Animal
Nutley,
with
was allowed
All laboratory
Medical for
Center the
rules were
hydrochloride
for facimeet
Accredita-
Care) guidelines,
of the animal
free
Laboratory
to the new environ-
this study.
lities in the St. Louis University tion
Rodent
1 week
This
testicular
per cage
Purina
and adaptation
prior to entering
weighing
used for this study. of spontaneous
and
Chow ment
the
Sprague-Dawley
Indianapolis)
265 g were
has a low incidence Four
in
rat.
Eight-week-old
access
procarba-
cytotoxicity
METHODS
lesions.
the quantita-
between
testicular
AND
the
used
we describe
rats (Harlan-Sprague-Dawley,
of recovery
to circumvent
chemotherapy Mice
of
at Grand Blvd., PO Box 15250, St. Louis, MO 63110-
0250, USA.
were
MATERIALS
strain
their
Louis
testicu-
of procarba-
relationship
and
Sprague-Dawley
document
but
a surgical
St.
testicular
dosage
federal
Avenue
count,
lung, liver
rat, testicle.
approximately
and
Correspondence:
head
using this regimen.
are quite scanty.
reports method
available.
endocrinological tigating
have
persists
testicular
[4],
greater
who
develop
an efficient
procedures
assume
men
drugs
many
the
As the delayed
Data on the frequency
effect
USA.
these
[l-3].
is not
mg
evaluated
at day 59 for procarbazine
and qualitative
zine
chemo-
with
in this patient
evaluate
hypoplasia
LD,,
procarbazine,
increases,
agents
young
of fertility phenomena,
undergo
in the
survivors
treatment
adverse
year
anti-cancer Many
fertility
patients
each
importance.
Although
sperm
dosages
in
(O-700
was
dose-dependent
and intermediate
tive hundred
which
toxicity
on heart,
the rat [5]. In this report,
Several
spermia
weight,
to avoid drug-induced
INTRODUCTION
of
testicular
toxicity
Progressive
rat,
1993; 2: 77-81.
Keywords:
toxicities
in the
one, and have gener-
of procarbazine
body weight).
600 mg kg-’
the study of techniques
evaluated
bolus of procarbazine Testicular
by testicular Effects
St. Louis, MO, USA
we describe
later.
qualitatively.
occurred
to be approximately
will facilitate
days
and quantitatively
and epididymal were
has been
In this report,
59f2
Center,
than the intravenous
a single intravenous
necropsy
qualitatively
zine. Marked
other
regimens.
rat following with
Medical
of procarbazine
routes
multiple-dose
weight),
St. Louis University
cytotoxicity
have utilized
the Sprague-Dawley kg body
W. G. DOUBEK*, K. C. TOLMAN* AND C. G. JANNEYt
and tPatho/ogy,
testicular
models
of intravenous procarbazine in rats
and all
followed
during
experimentation. (a gift from
NJ) was dissolved
Hoffman-
in sterile
0.15
M
F. E. Johnson et al.
78
NaCl immediately wide
prior to administration.
range of dosages
tions were
prepared
were
in order to insure precision
dosage. Acute fluid overload ing the volume
Because a
used, five concentrawas avoided
of all injectates
in
by keep-
between
0.4 and
Both
testes
weighed
to
Forty rats were assigned to five treatment with eight rats in each group. Identifying ing was done after grouping.
was expressed necropsy
to estimate
groups,
evaluation albuginea
to f 1 g on the day of drug administration
(desig-
of sperm M
sodium
pentobarbital
(60
(BW), with supplemental given
as needed).
established
mg
Intravenous
while
PT 10, Brinkmann)
weight
(i.v.)
BW
access
was
in order
extravasated.
Rats in
hematoxylin
were performed
and incisions were
closed
with fine polyglycolic
acid sutures. On each operat-
ing
each
rats
from
treatment
weeks
were
upon in rotation in order to minimize tech-
nique bias. All animals were operated 4-day
group
period,
then
inspected
and weighed
weekly.
upon within a
daily for the first 2 Those which
expired
prior to the day of necropsy were not replaced. postoperative
day
592 2, all surviving
killed by exposure to CO2 and necropsied.
On
rats were The testi-
speed
between
as described
head count was estimated
micro-
hemocytometer
tech-
(KCT) to ensure
reproducibility.
BW,
(Table 1). All cutdowns
rinsed
of the homogenate
nique [6] by a single investigator
at 100, 300, 500 and 700 mg kg-’
2 through
the tunica
maximum
tip was
using conventional
were
in groups
under sterile conditions
operated
scopically
pro-
respectively
day,
by others. Sperm
5 received
those
at 80%
was serially diluted, but not sonicated
NaCI,
0.5 ml of i.v. 0.15
after
it was homogenized
and the final volume
M
1 then received
carbazine
body
by internal jugular vein cutdown
to ensure that no procarbazine group
kg-’
doses of 15 mg kg-’
at
NaCl using a Polytron homogenizer
samples,
(i.p.)
epidi-
of procarbazine-
count:
had been removed,
in 2 ml of 0.15 (Model
head
rats were
intraperitoneal
and
of the
of body weight
the degree
for 5 s. The homogenizer
with
necropsy
The left testis was then used for
nated day 0) and on the day of necropsy. On day 0, anaesthetized
at
removal
as a percentage
atrophy.
ear notch-
All rats were weighed
excised after
dymides. The total testicular wet weight (right + left)
induced
1.2 ml.
were
f 1 mg
Samples
were
fixed
of heart, left lung, liver, and left kidney in
10%
formalin
and
and eosin for histologic
qualitatively
assessed
stained study.
by a single
with
All slides
pathologist
(CGJ). fixed
in
Bouin’s solution for 3 h, then cut perpendicular
to
The
right
testes
and
epididymes
their long axes into several 2-3-mm fixed again in Bouin’s solution
were
thick slices and
overnight.
day they were fixed in 70% ethanol
The next
saturated
LiCO, for 24 h, and finally in 10% buffered for several
days
before
processing
histologic slides using hematoxylin These
slides were
cles, heart, lungs, liver and kidneys were inspected
regard
to germinal
for gross abnormalities.
tissue,
Leydig
scored
cells,
Sertoli
into standard and eosin stain.
by the pathologist
epithelium,
vessels,
cells,
with
formalin
and
with
interstitial epididymal
Table 1. Effect of procarbazine on animal body weight, total testicular weight, sperm head count, repopulation index, epididymal index, modified Johnsen score Group
Dose
No.
Body weight
(mgkg-‘)
surviving
gain (% of
to necropsy
original BW)
date 1
0
8
46.1 k5.4
Total testicular weight Absolute
Normalized
(9)
(% BW)
3.613kO.058
0.909kO.022
Sperm
Repopulation
Epididymal
Modified
head count
index
index
Johnsen
(per testis)
29.21 k1.83
score
0.997kO.002
3kO
13.4k0.2
0.999kO.001
3+0
13.2F0.2
0.798zkO.100
2f0.33
10.8kO.7
0.624kO.093
1.33f0.21
8.5f0.2
0.356
1
8
(X106) 2
100
8*
47.1 f2.2
3.472rk0.111
0.873+0.022
27.85k2.80 (X10")
3
300
8
42.6f4.1
2.556f0.302
0.663f0.082
14.99f2.24 (X106)
4
500
6
43.5zk3.3
1.772k0.154
0.473kO.051
3.88k4.54 (X106)
5
700
1
44.6
1.302
0.350
7.8X lOa
*One animal was censored for testicular weight and sperm head count because of a congenitally absent left testicle.
79
Procarbazine toxicity structures
according
Johnsen
scoring
viously findings
is assigned
are assigned
obtainable
The number testis.
The
of
paraffin
To
maximum
scale
1 + = markedly
to
coding
as the
dosage.
Increasing
scale than
number
index
the slides
remained
determine
factor
index
variation
groups
were
of variance effects.
In the
the two-sample
are expressed
with
generally a Tukey
case
binomial
test
of epidi-
test was used.
Histologic showed each
and
animals
Group
and seven
of the eight
died
after
soon
drug
receiving
appeared
healthy,
the rats which
and delayed
tion
arrest lined
anaesthetic
since none
of the animals any
anaesthetic rarely
None period
regimen
or thoracic
routinely
anaesthetic
which
appeared
higher
dose
congenitally
any gross
viscera,
with small
did not occur. we
procarbazine
and
of the rats which showed
were
tent with
in the lower
mortality,
encounter
BW rats
on day 0 could
due to acute
since
have
believe toxicity,
dose groups we
use
in our laboratory
this and
difficulties. survived
the entire
abnormality the exception
and
soft
study
in groups minimal
One animal
in group
left
This
2 had a
animal
was
of
Approximately were
examined
tion
index.
between
animals, tubules cells
tubules
stage,
maturaas well
disruption
numerous
Sertoli-only (Fig. Ic). There
in the epididymal sperm
group
3,
4 and
examined
con-
of sperm mixed
and
with
empty
5. There
infiltrates, tubules
or
was
vasculitis,
no or
(range = 512-1595) the repopula-
differences
were
99%. The repopulation
0.80 for group
approximately
(repopulation
4
of sper-
1 and 2 as the repopulation
to about
as
cells (Fig. 1 b). Group
per testis to determine
above
(Fig.
maturation
and appearance
No significant
uniformly
com-
containing
cells in any of the testicles.
750
groups
2 showed
disrupted
2, diminished
of Leydig
the
cross-
virtually
spermatozoa
in groups
of
populated
with
in
bron-
rest
of maturation
greater
inflammatory
abnormalities
dropped
absent
sperm
animal
incomplete
changes
debris
evidence
of the testes, in the
1 and
eosinophilic
was
in animals
by Sertoli
amount
kidney
One
tubules
exhibiting
maturation,
and
1 and
with
fully
and few mature normal
of
rats is
of the testicular
had
showed
corresponding
in abdominal
groups.
testicle.
tubules
All other
complications,
were
BW
IO4 in the
patchy
the
at the spermatid
only
a per
lungs.
seminiferous
those
5 animals
700 mg kg-’
deaths
died
the deaths suffered
500 mg kg-’
administration.
Although experienced
receiving
all
groups
normal,
among
matocytic animals
but normal
3 animals
scattered with
liver
cells at all stages
with
X
in untreated
histology,
repopulated
count
coefficient
5 had mild,
from
normal
The
drug
caused
head
heart,
examination
spermatogenic
and
Two of the eight
2, 4 and
of animals
essentially
values
increasing
abnormalities.
pneumonia,
Microscopic
pletely
of
had essentially
tubules RESULTS
sections
in groups
are
a progressive
1 to 7.8
count
a
[7].
no discernable
chiolitis
la).
head
0; results
dosage
5 rat.
as
(absolute
sperm
IO6 in group
group
of sperm
arrest,
as mean + SEM.
in
in our laboratory
sections
among
X
29.21
weight
procarbazine
surviving
procarbazine,
was
BW) with
reduction
from
4-12%
of the slides throughout
of evaluation. by analysis
testis single
reduced
and O=absent.
was used for all slides.
evaluated
progressive
epi-
expressed
on day
testicular
of The
epididymal
in total
head in the
index,
of
was
1. There
as percentage
was also
(but greater
decrease
effects
weight
in Table
included
score.
necropsy
of body
of sperm
but
repopulation
systemic at
as well
et a/. [8]. index.
weight,
and
number
epididymis
content);
number
Differences
All results
total
using a numerical
content);
to the group
of sper-
counted
by Kramer
2 + = reduced
who
signs
also
repopulation
is referred
the process
percentage summarized
the
evaluated
The investigator
evaluated
the
30% of normal
[7]. Random
was right
the analysis
weight
and Johnsen
evaluate
of the
with
body
weight
sections
was of
of
section
from
testicular
index,
tubular
in the ductus
normal
(less than
dymal
of 1. The
excluded and
body
is called
3 + = normal;
count didymal
as described
of sperm
therefore analysis
of tubules
semi-quantitatively
to
the pre-
sugges-
as a fraction
sections
This fraction
blind
of used
any abnormality
repopulation
expressed
where
have
a score of zero and normal
of seminiferous
number
matogenic
amount
we
a score
in an intact
tubular
modification
score is 14.
counted
This
the which
[7]. In this system,
tive of injury
30%
to
system
were
38% devoid
of
noted index index
3 rats. In group all of
seminiferous spermatogenic
index = 0.62), while
the majority
4
F. E. Johnson et al.
80
Figure 1. (a) Testicular from
Group
normal
tubules
each tubule.
of maturation
H&E stain,
magnification. partly
repopulated in rare tubules.
Group
tubules,
populated
cells. H&E stain,
(64%)
matogenic
cells and were lined by Sertoli cells only
(repopulation
in the group
index = 0.361,
5 rat had no sperindicating
stem cell killing by procarbazine from epididymal ally paralleled count,
dependent
the results obtained in groups l-2
while
other
decrease. content
dymis to another. documented 0.15
groups
showed
are
one portion
In previous
work
group,
as compared
indicating
that
procedure
approaches
induced
toxicity
hormonal regimen.
to germinal
[IO],
epithelial
in drug treatment is often viewed as
this problem
approaches
in
macokinetics
offer another potential
to modify
in
that a mechanical testicular
[9], we have
tory isolation,
and
which we have termed provides
doxorubicin-induced allows
doxorubicin-treated
anesthesia
nor the
has influenced
results
[5],
long-term
partial
germinal
retention
animals
Sprague-Dawley
of
single-dose
testicular
investigators
of fertility
in
[13], and produces
no
rat as an appropriate
intravenous
patient With
is becoming recent
percentage
an
progress of long-term
important
in
cancer
survivors
rise. Thus, late toxic effects assuming
more
mented;
cells represents
another
the to
are now
Prolonged
infertility
in young
chromosomal
treatment, has continued
of treatment
importance.
after chemotherapy
consideration.
males
is well
docu-
sterilization carbazine
of young
male
is often considered
lar injury in a number
and the formation
Pro-
as a cause of testicuprotocols
and
[I -31. on stem cell regeneration
of spermatozoa
to spermatogenic
genitor
potential
long-term
tion, infertility generally develops
hazard.
drugs in
patients.
to act as an alkylating
damage
cells. Following
injury
as a class,
implicated
of lymphoma
regimens
Male fertility depends
testicular
agents,
cancer
agent and has been implicated other treatment
procarbazine-
in limiting
The alkylating
are perhaps the most commonly cancer
epithelial
injury which should be useful for
interested
from this agent. male
circula-
of the rat
effects itself [7]. The current work estab-
lishes the model
groups.
partial protection
testis from injury
young
to pro-
approach,
in any
in the
method
[II, phar-
tect fertility. We have documented
variability
DISCUSSION of fertility
regional
of the epidi-
induced
Retention
also, but
available data suggest it is seriously inadequate
control
in the procarbazine-treated
including
germinal
and alteration
a suitable way to circumvent
difference
neither
epithelium,
of
Semen cryopreservation
with a non-treated
employed
germ
have been used to avoid drug-
manipulation
metabolism
by immature
x 100 magnification.
121. Surgical
a dose-
that animals receiving anaesthesia
parameters cutdown
sperm
summarized
no appreciable
from
NaCl have no significant
M
by repopulation
had a normal
These
Table 1. We observed the sperm
in this group. Data
index and sperm head count gener-
index. Animals head
extensive
Several
BW)
many entirely
of germ cells, and some
sparsely
of tubules
H&E (c) Testis
5 rat (700 mg kg-’
has shrunken devoid
3
shrunken
by
X 100 magnification.
from
Group
BW) shows
germ cells, with few
spermatozoa stain,
in
X 100
(b) Testis from
rat (300 mg kg-’ immature
rat showing
with spermatogenic
cells in all stages
tubules
cross-section
1 (control)
cytotoxic
from these prodrug administrarap’rdfy from lethal
Procarbazine
damage
to the differentiated
of fertility
depends
cells,
which
yield
differentiated
produce
on
repopulate
the tubules
identification
of stem
morphology,
which
to
stem
measure
involves
absence
Conversely,
cross-section
This assay
stem cell within
suffers
from
insensitive this
is
before
issue,
we
epididymal extent
injury
have
index
able technique
used
primary We The
and spermatids.
spermatogenic about
exposure
should
provide
sufficient
new
through
generation
which
supports
Spermatogenic tiated
time
should
have
which
supports
The
the
already
to
normally
stem
the differential
pathway
differentiated
sperm
repopulation already
procarbazine
to
cells, index.
testicular
is in general
within
[4], as well
given
procarbazine
from
ours,
as the results
underestimate
the
JAMA
with
as
observed
in
the findings
observed
damage.
1988; 259: 2123-5.
3. Schilsky RL, Lewis B, Sherins RJ, Young RC. Gonadal
dysfunction
in patients
receiving
cheomotherapy
cancer. Ann lnt Med 1980; 93: 109-l 4. 4. Meistrich ML, Finch M, da Cunha MF, Hacker Au, WW. peutic
Damaging
drugs
effects
on mouse
of fourteen
testis
cells.
5. Lui RC, La Regina FE. Regional toxicity.
MC, Herbold
doxorubicin
for
U and
chemothera-
Cancer
Res 1982;
DR, Stern JA, Johnson
delivery
reduces
testicular
J Surg Res 1987; 43: 286-95.
6. Meistrich
ML, Hunter
after
NR, Suzuki N, Trostle
regeneration
exposure
of
mouse
to ionizing
PK. Withers
testicular
radiation.
7. Stern
JA, Lui RC, LaRegina
KC, Johnson
stem
Radiat
MC, Herbold
FE. Long-term
lar ischemia
outcome
Res
in rats
MeV fast-neutron
irradiation
liferation
in mice;
influence
testicu-
different
intervals.
9. Lui
RC,
La
Testicular
on spermatogonial
pro-
of dose fractionation
with
lnt J Radiat Bioll974;
Regina
MC,
cytotoxicity
of
Herbold intravenous
Johnson
FE.
doxorubicin
in
rats. J Ural 1986; 176: 940-3. LM,
Robinson
analog
of
J, Gould
induced
SG.
testicular
gonadotrophin-releasing
Protection damage hormone.
from with
an
Lancet
1981; 1: 1132-4. 11. Milligan
DW,
preservation
Hughes
- a UK survey. 12. Redman
R, Lindsay
in men undergoing Br J Cancer
JR, Bajorunas
13. Liebscher
of body weight
may actually
Johnson
GJ, Janney
artificial CG, La Regina
FE. Preservation
administration.
Semen
cryo-
chemotherapy
1989; 60: 966-7.
DR. Goldstein
of testicular
disease.
KS.
cancer
of expression
as
25: 253-60.
DR,
J C/in Oncoll987;
produced,
DR. Tolman
following
1990; 11: 390-395.
in the rat. J Androl
Hodgkin’s
to schedules
of atrophy
or
of gonadal
gonadal
different
degree
of childhood
JD. The relationship
and
Our method
as a percentage
survivors
cryopreservation
according
evaluate
NEJM 1987; 317: 1315-7.
and chemotherapy-induced
cyclophosphamide
59 days,
head count
atrophy
agreement
to
JJ, Myers MH, et al. Effects of treatin long-term
2. Rivkees SA, Crawford
10. Glode
differen-
administration
left the testis
suitable epithelium.
8. Kramer MF, Davis JAG, Van Der Ven TPA. Effects of 1
be longer
of stem cell survival.
our study
weight
late
of reasons.
rat
the use of the sperm
dose-related
in mice
of
be
germinal
cancer.
the
time for the surviving
were
adolescent
cells
days
which
on fertility
HR. Gradual
Fifty-nine
use of the
cells
at the
measure
of
avail-
due
even
insult.
should
injury
1978; 74: 349-62.
the
may
ment
dehydro-
damage
in
and
to a cytotoxic
cells to progress
by
for a number
cycle
48 days
The
is assay of a
only
here
to protect
period.
testicular
42: 122-31.
assay of the
lactate
testicular
on day 59+2
is seen. important
currently
spermatocytes the
is
routinely.
assayed
requires
are
functional
produced
area.
killing
tubule
Another
of
of toxins
clinically index
described
activity
it is
cell
isoenzyme, is
to a
that
(not used in this study)
which
procarbazine
a
this
is a second
germ-cell-specific
after
is the
the
the presence
doses
of procarbazine-induced
1. Byrne J, Mulvihill
repopu-
the immediate
low
of stem cell survival.
genase-X,
each
extensive
of procarbazine the study
REFERENCES
time
proximity
a non-repopulated
severe
so
when
doses during
popular
the disadvantage
because
However,
methods
result from
indicates
the higher
less weight
difficult
at a given
in sufficient
receiving slightly
epithelial
most
tubules
gained
measures
and non-repopulated
cross-sections
cells
at least a single
required
The
then
fertilization.
is rather
cross-section.
lated tubular
relatively
survival.
repopulated
of stem
used;
cells
Non-repopulated
particular
for
has led to alternative
tubular
after injury.
cells, which
animals
The model
eventually
of spermatogenic
cell
counting
seminiferous
of stem
and
spermatozoa
due to the complexities
Return
survival
spermatogenic
sufficient
Visual
spermatocytes.
adequate
81
toxicity
Surg Forum
of fertility
MC, et a/. Semen insemination
for
5: 233-8. MC, Tolman after
KC,
doxorubicin
1990; 40: 680-2.